Alzheimer’s-Gut Links; Long COVID and ME/CFS; ALS Patient Gets Novel Brain InterfaceJuly 20, 2022
Genome-wide association studies revealed significant genetic overlap and correlation between Alzheimer’s disease and gastrointestinal tract disorders. (Communications Biology)
Depressive symptoms emerged in the years both before and after incident stroke. (Neurology)
High adherence to a Mediterranean diet was associated with better cognitive performance, and less learning and memory decline, among middle-age and older Hispanic or Latino adults. (JAMA Network Open)
The FDA approved the first oral liquid formulation of the anti-seizure medication zonisamide (Zonisade), Azurity Pharmaceuticals announced.
Quantitative MRI showed microstructural changes in the striatum was associated with early Parkinson’s disease. (Science Advances)
How might long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) be similar? (Frontiers in Neurology)
Circadian dysregulation due to shift work was tied to stroke severity. (Neurobiology of Sleep and Circadian Rhythm)
More research — this one in mice — linked gum disease and Alzheimer’s disease. (Frontiers in Aging Neuroscience)
Roche’s Elecsys amyloid plasma panel to help diagnose Alzheimer’s disease won an FDA breakthrough device designation, the company said.
When patients became chronic opioid users, the risk for opioid misuse among family members doubled. (JAMA Network Open)
An ALS patient at Mount Sinai West in New York received the first endovascular brain-computer interface in the U.S., device marker Synchron announced.
Restricting personal decisions on childbearing may change aspects of treatment for women with MS, epilepsy, and migraine. (JAMA Neurology)
A mouse study suggested where memory fragments might be stored. (Nature)